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Unintended pregnancy is a persistent public health problem that has seen a recent 
decline in prevalence. The decline in unintended pregnancy rates is largely due to the 
increased use of highly effective reversible contraception (HER-C) methods such as 
intrauterine devices (IUDs) and implants. With relatively few women selecting HER-C 
methods in the United States, research has focused on reducing cost barriers to accessing 
these methods.  
The Highly Effective Reversible Contraceptive Initiative (HER Salt Lake) is a 
prospective cohort study examining the social and economic impact of removing out-of-
pocket costs for contraceptive methods provided at federally-funded Title X family 
planning clinics in Salt Lake County, Utah.  This retrospective medical record review 
assesses changes in contraceptive method uptake between the control period, with 
standard of care payment schedules, and the intervention period, when all out-of-pocket 
contraceptive costs were removed for eligible patients.  
This analysis focuses on self-pay patients ages 16–45 initiating a new 
contraceptive method. Demographic information along with service descriptions and 
prescription information was obtained from the Planned Parenthood electronic medical 
record system. Contraceptive method distribution and demographics were compared, 
logistic regression models were used to identify associations with selecting a HER-C 
method during the intervention period, and multinomial regression models were used to 
		 iv 
find the selection probability of different types of HER-C methods available compared to 
non-HER-C methods.  
The unit of analysis is the number of new contraceptive visits (prescriptions refills 
were excluded). The sample included 6,021 clinic encounters, the control period 
accounted for 2,922 and the intervention period 3,099. In the control period, 16% chose a 
HER-C method compared to 26% in the intervention period. During the intervention 
period, the odds of selecting a HER-C method were 1.8 times more likely compared to 
non-HER-C methods holding covariates (age, race/ethnicity, pregnancy history, county of 
residence, and clinic location) constant. The implant saw the largest proportional increase 
in uptake from 4% to 11%.  
This study contributes to knowledge surrounding self-pay patients who present to 
Title X funded clinics. This analysis has effectively demonstrated a desire for HER-C 
methods. Continued efforts are needed to promote access to and increase awareness of 
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Unplanned pregnancy research has mostly focused on preventing the negative 
outcomes associated with such births. Research has shown that women who have 
unintended pregnancies that result in birth are at an increased risk of physical and mental 
health problems and initiate prenatal healthcare later than otherwise comparable women 
having planned births (Kost & Lindberg, 2015). In addition to adverse health outcomes, 
unplanned pregnancies impose a societal burden as these women are less likely to 
achieve their economic and educational potential (Darroch, Sedgh, & Ball, 2011). There 
is also a societal burden associated with unintended pregnancies as public insurance 
programs pay for a large portion of all births and maternal medical care (Sonfield, Kost, 
Gold, & Finer, 2011).  
The unintended pregnancy rate is a commonly-used public health indicator of the 
quality of family planning services. For many decades, half of all pregnancies in the 
United States were unintended, the highest rate among developed countries (Singh, 
Sedgh, & Hussain, 2010). After many years without progress, there is now evidence of 
improvement. The rate of unintended pregnancy in the United States declined from 51% 
in 2008 to 45% in 2011 (Finer & Zolna, 2016).  
There are multiple factors associated with why unintended pregnancies rates have 
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not declined until recently.  These include barriers to contraception such as lack of patient 
and provider knowledge, cost, and fear of pain or side effects (Kavanaugh, Frohwirth, 
Jerman, Popkin, & Ethier, 2013).  In addition to the recent decline in unintended 
pregnancy rates, there were also developments in newer and more effective contraceptive 
methods. As barriers to contraceptive methods break down and new methods are 
developed, providers need continuing education to ensure accurate knowledge and 
effective communication with patients (Rowlands, 2009).   
The decline in unintended pregnancy rates is largely due to the recent increase in 
use of highly effective, reversible contraception (HER-C) methods, such as intrauterine 
devides (IUDs) and implants).  These contraceptive methods not only have a very low 
failure rate, but also a high continuation rate (Peipert et al., 2011; Trussell & Guthrie, 
2007). The American Congress of Obstetrics and Gynecology recommend the use of 
IUDs and implants as the first-line option for reducing the unintended pregnancy rate 
(Committee on Gynecologic Practice Long-Acting Reversible Contraception Working 
Group, 2015).  
Consistent and proper use of contraception is essential to preventing unplanned 
pregnancies (Sonfield, Hasstedt, & Gold, 2014). Yet, the most commonly used 
contraceptive method in the United States is the oral contraceptive pill which requires 
daily use (Mosher & Jones, 2010). Oral contraceptives have a typical-use failure rate of 
8% (Hatcher et al., 2007). Most women use a contraceptive method with adherence 
requirements and the majority of pregnancies result from incorrect or inconsistent method 
use, with only 5% resulting from method failure (Frost & Darroch, 2008). Over time, 
IUDs and implants are more than 20 times more effective at preventing pregnancy 
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compared to combined hormonal methods (e.g., birth control pills, patches, and vaginal 
rings; Winner et al., 2012). In the United States, use of HER-C methods increased 
significantly between 2007 (3.7%) and 2009 (8.5%) and continued to grow to 11.6% in 
2012 in popularity (Kavanaugh, Jerman, & Finer, 2015). However, there may still be 
opportunities for growth, particularly in environments with limited insurance coverage 
where a significant portion of the population is paying out-of-pocket for services.  
This study assesses the cost barrier for women obtaining contraception and if 
removing out-of-pocket costs for all reversible contraceptive methods changes the 
contraceptive method mix and uptake of the most effective methods.  
 
1.1 Literature Review 
Family planning advocates have long recognized an unmet need for more 
widespread contraception access (Bongaarts & Bruce, 1995). This unmet need for 
contraception is used as an indicator of maternal health and can be interpreted as a lack of 
access to contraceptive supplies (Mills, Bos, & Suzuki, 2010). Although access is crucial, 
it is not always the reason why women do not use contraception to avoid pregnancy. 
Women have identified many other reasons besides overall access that impede utilization 
of family planning resources. 
Some women cite lack of awareness, concerns about pain of insertion, or side 
effects of IUDs and implants as reasons why they chose less effective contraceptive 
methods (Hubacher, Spector, Monteith, Chen, & Hart, 2015).  A previous study identified 
that males are more likely to have stronger views than women that birth control interferes 
with sexual pleasure, which present a partner-related barrier into contraceptive use (Pesa, 
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Turner, & Mathews, 2001).  Still, the most widely studied barriers to any form of 
contraception seem to focus on lack of information, limited availability, and cost (Forrest, 
1996; Trussell et al., 2009). Combatting these barriers will likely include patient-centered 
initiatives to make more contraceptive options available. Additionally, improved 
understanding of method acceptability, better education, and counseling both during and 
after method selection may also improve patient experience and support reproductive life 
goals and community health.   
While individual and community factors impact women’s access to services and 
contraception, simply making contraceptives available does not ensure that women will 
use them, as cost associated with contraception is an element that limits overall access 
(Frost, Singh, & Finer, 2007). Often times, the highest unmet need for contraception is 
found among women who are poor (Singh & Darroch, 2012). In the United States, the 
most effective contraceptive methods are also the costliest to access (Kavanaugh et al., 
2015). Estimates of the cost of contraception vary, but HER-C methods have a higher up-
front cost than traditional contraceptive methods (Trussell et al., 2009). HER-C methods 
can cost up to $600 out-of-pocket, whereas pills are $18 a month.  
HER-C methods have a low failure rate, similar to sterilization (Meirik, Farley, & 
Sivin, 2001), but the high initial cost and removal cost may be a significant barrier for 
women to obtain these “set it and forget it” methods, especially among young and/or poor 
women. Poverty is an important predictor of unintended pregnancy, as women with 
incomes below the federal poverty level have over a five-fold increased risk of 
unintended pregnancy relative to women with higher incomes (Finer & Zolna, 
2016). Cost of contraceptive methods has been shown to be an important motivator for 
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low-income women when choosing a method (Secura, Allsworth, Madden, Mullersman, 
& Peipert, 2010).  A survey of 18–30 year old women found that both expense of method 
and insurance coverage are concerns when choosing a contraceptive method (Spies, 
Askelson, Gelman, & Losch, 2010).  
The Affordable Care Act (ACA) has reduced the cost barriers to access HER-C 
methods. Under the ACA, private insurance plans are required to include coverage of all 
Food and Drug Administration-approved contraceptive methods without deductibles or 
copays (U.S. Department of Health and Human Services, 2012).	The federal 
contraceptive coverage requirement has already initiated a decline on the proportion of 
women having to pay out-of-pocket for the hormonal IUD (Bearak, Finer, Jerman, & 
Kavanaugh, 2016).  However, women may still be (partially or fully) monetarily 
responsible as a result of exceptions to the ACA mandate. Specifically, some older 
insurance plans have been allowed to continue their contraceptive exclusions 
(Blumenthal & Collins, 2014) and the ACA also exempts contraceptive coverage for 
health insurance plans provided by religious employers (Melling, 2015). Women wanting 
an IUD may face a higher financial burden if their insurance plan has deductibles or co-
pays for insertion and removal of a HER-C device (Finer, Sonfield, & Jones, 2014). 
While insurance companies may be adhering to the law, some women with private 
insurance may still have to pay the full cost for contraception (Bearak et al., 2016). This 
variance in insurance coverage can create uncertainty and limitations for individuals 
seeking contraception.  
Title X family planning clinics generally provide services to low income, 
uninsured women. These services help women achieve reproductive goals and also save 
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public funds. Research has shown that preventing unintended pregnancy is cost-effective. 
Data from the Guttmacher Institute revealed that prevention of unplanned pregnancies 
through public funding for contraception yielded a public savings of $10.5 billion for 
2010 (Frost, Zolna, & Frohwirth, 2013). Medical costs associated with unintended 
pregnancies include prenatal care, potential for pregnancy complications, and deliveries. 
Avoiding unintended pregnancies saves taxpayers $4 for every $1 spent on family 
planning services (Gold, Sonfield, Richards, & Frost, 2009). In terms of HER-C methods, 
for every $1 spent, $7 was saved (Foster et al., 2009).  
To continue to make progress in family planning services, it is essential to build 
and expand from previously demonstrated community projects. Evaluations of projects in 
Missouri, Colorado, and Iowa found that supporting use of HER-C methods through 
contraceptive counseling and removing cost barriers reduced unintended pregnancy and 
abortion rates (Biggs, Rocca, Brindis, Hirsch, & Grossman, 2015; Ricketts, Klingler, & 
Schwalberg, 2014; Secura et al., 2010).  
The Iowa Initiative in 2007 involved implementing advocacy, education and 
reducing cost barriers with the intended goal of increasing family planning services 
locally. The Iowa Initiative also involved a public marketing campaign and provided free 
IUDs and implants. Through these efforts, the percentage of Iowa Title X reproductive-
aged clients using HER-C methods increased from 1% to 15% (Biggs et al., 2015).  
The CHOICE Project in St. Louis, Missouri, provided free contraception, and 
developed a standard educational script informing women of the most effective methods. 
The CHOICE project, while offering all methods of contraception, found  that 75% of 
participants chose a HER-C method at enrollment (Birgisson, Zhao, Secura, Madden, & 
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Peipert, 2015). The rate of unintended teen pregnancy in this study was more than four 
times lower than the national rate (Secura et al., 2010).   
The Colorado Family Planning Initiative (CFPI) was introduced in 2009.  This 
initiative used private funds to provide HER-C methods and the contraceptive ring at 
local Title X clinics.  The CFPI, in addition to covering these device costs, provided staff 
and provider training for counseling techniques and insertion procedures. The state of 
Colorado saw an overall decline in teen pregnancies following the start of the CFPI. The 
teen birth rate for 15–19 year olds declined 26% from 2009 to 2011 (Ricketts et al., 
2014). Following these demonstrated health and cost benefits, public health advocates in 
Colorado urged legislative funding for these initiatives and ultimately received $2.5 
million in 2016 (Bower, Japinga, Sabin, & Ward, 2016).  
These earlier studies provide some guidance for the current investigation. These 
previous studies provide evidence that support the hypothesis that a cost barrier does 
exist and impact method selection. A sampling limitation with the CHOICE project is 
that partial recruitment was conducted at abortion clinics. Research has shown that 
women faced with an unplanned pregnancy are more motivated to use more effective 
forms of contraception than otherwise comparable women who are not facing an 
unplanned pregnancy (Rose, Cooper, Baker, & Lawton, 2011).  Another recruitment 
drawback for these prior projects was that their community promotion tactics included 
newspaper reports and flyers. This targeted promotion had the potential to unwittingly 
attract women with a preconceived interest in HER-C methods; artificially raising the use 
of HER-C methods among women cared for at participating clinics.   
This current observational study will look at a cohort of eligible women seeking 
		
8 
contraception at Title X funded family planning clinics. This study will build on previous 
research and assess general contraceptive method selection specifically as it relates to the 
cost barrier in a more natural setting while assessing individual level data from electronic 
medical records. The protocol used specified that all qualifying women seeking a new 
contraceptive method at participating clinics would have the ability to receive their 
desired method for free. While some previous initiatives focused on providing 
specifically HER-C methods for free, this project allows for selection of all contraceptive 
methods that are available at the participating clinics. Previous projects assessed HER-C 
method uptake at enrollment, whereas this project has a quasi-experimental design 
allowing for analysis of how removal of the cost barrier impacts the contraceptive 
method selection for uninsured patients.  
 
1.2 Study Aim and Hypothesis 
This analysis compares proportions of contraceptive method choices at three Title 
X funded Planned Parenthood Association of Utah (PPAU) clinics among qualifying 
uninsured women during two six-month periods; a baseline standard of care period and 
then during an intervention period, when the cost for all contraceptive methods provided 
at the participating clinics is removed. When the cost barrier is removed, women are 
hypothesized to be more likely to choose a highly effective method of birth control, 







METHODS AND MATERIALS 
 
In states that have not expanded Medicaid coverage under the ACA, women with 
limited resources still face significant cost obstacles to obtaining these highly effective 
methods. In 2014, the Utah legislature voted against Medicaid expansion under the ACA. 
One of the largest providers of contraceptive services in Utah is PPAU. In 2015, PPAU 
served 46,082 patients, and 86% of those patients were uninsured (Planned Parenthood 
Association of Utah Annual Report, 2015). PPAU provides reproductive health services 
and contraception through Title X funding. PPAU is able to use a sliding scale to meet a 
patient’s financial needs within the budgetary limits of the organization (see Appendix 
A). Due to a high level of need in Utah, PPAU subsidizes reproductive health care in 
Utah with additional funding.  This additional funding is collected through charging 
patient fees, donations, and private fundraising. In some cases, patients desire methods 
they are unable to afford and PPAU is unable to provide them at a reduced cost, which 
has resulted in an unmet demand. The methods that PPAU are unable to provide on a 
sliding-fee scale are the Mirena IUD and Nexplanon implant (Appendix B), which are 
some of the most use-effective birth control methods. Due to this limitation in public 
funds for family planning services, low-income women in Salt Lake County likely face 
cost barriers to access these most effective forms of contraception. 
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The Highly Effective Reversible Contraception Initiative Salt Lake (HER Salt 
Lake) is a collaborative research study between the University of Utah and PPAU in Salt 
Lake County.  This ongoing prospective cohort study examines the social and economic 
impact of removing cost barriers for all FDA approved reversible methods of 
contraception. The University of Utah’s Institutional Review Board approved the HER 
Salt Lake study (IRB #65794).  
The University of Utah’s Family Planning Research Group and PPAU 
implemented a control period and an intervention period. During the 6-month control 
period, women who came to the clinics received standard care and faced PPAU’s 
standard costs (with some contraceptive options having a sliding fee based on income 
while others did not). Cost barriers for all contraceptive methods for clinical care were 
removed during the intervention period.  
 
2.1 Time Frame for Study Periods 
The baseline six month control period was 9/28/2015 to 3/27/2016. The 
intervention period followed during the next six months from 3/28/2016 to 9/25/2016, 
when all qualifying women received standard care and the ability to obtain their 
contraceptive method of choice at no cost (Figure 1). 
 
2.2 Eligibility Requirements 
For the purposes of this study, the sample population included qualifying, self-pay 
contraception visits at any of the three Title X funded PPAU clinics in Salt Lake County. 
Patients were included in the sample if they were: (a) between the ages of 16–45 during 
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the study period, (b) a new patient to PPAU or an existing patient initiating a new 
contraceptive method (as both new patients and contraceptive-focused visits received the 
client-centered contraceptive counseling), (c) not relying on self or partner sterilization, 
and (d) were self-pay patients, as this is a proxy measure for having no private insurance 
or Medicaid coverage.  
 
2.3 Contraceptive Counseling  
Participating health clinics utilized client-centered contraceptive counseling based 
on the shared-decision making model and qualitative findings of Planned Parenthood 
Federation of America (Dehlendorf, Diedrich, Drey, Postone, & Steinauer, 2010; 
Dehlendorf, Krajewski, & Borrero, 2014; Makoul & Clayman, 2006). This counseling 
approach includes a standardized handout emphasizing method effectiveness (Appendix 
C) and ease of use, as well as semistructured open-ended questions. This script is 
designed to educate women about the most effective methods, emphasize accurate use, 
and educate patients on how best to avoid contraceptive gaps if switching methods 
(Appendix D). This conversation occurs at all nine PPAU clinics in the state and with all 
patients seeking contraception. PPAU clinic staff received extensive training for the 
contraceptive counseling approach in August 2015, prior to the initiation of the study 
control period. The contraceptive counseling has been incorporated with PPAU’s new 






2.4 Data Collection Tool: Electronic Medical Records 
Patients’ charts were reviewed from PPAU’s Electronic Patient Management 
(EPM) and Electronic Health Records (EHR). The EHR system includes demographic 
information, as well as medical histories, including sexual and reproductive health 
histories. The EPM system includes billing information applicable to identifying patients’ 
chosen contraception methods. The final data pull occurred after the completion of the 
intervention period. The dataset used in the current analysis included every visit from 
participating clinics (excluding emergency contraception visits and birth control supply 
sales) during the control and intervention period. 
 
2.5 Clinic Encounter Qualification Algorithm  
An algorithm was created to identify qualifying clinic encounters for statistical 
analysis (Figure 2). A report was generated from PPAU’s HER and EPM that included all 
clinic encounters during the study periods (N = 49,588 observations).  The clinics used in 
the analysis are the highest serving clinics in Utah located in Salt Lake County. Clinic 
encounters were excluded from the sample if the subject was not within the age range, 
was using insurance, or if the encounter did not have a qualifying service description 
code (N = 16,684 observations). PPAU clinical staff flagged all subjects in the medical 
record system during the study periods as either: “Qualified” or “Did Not Qualify.” 
Clinic encounters were included in the sample if prospective marking from clinical staff 
stated qualification (this was highly correlated with the naive assessment using 
aforementioned algorithm).  In conjunction with the assigned study status for each 
patient, billing visit codes identified qualifying clinic visits for the analysis as well as 
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written prescriptions (Appendix E). Due to using billing prescription codes to verify 
eligibility, condoms were not included in this analysis because PPAU does not document 
this in the medical billing system. Subjects selecting a diaphragm or emergency 
contraception and those with no method were excluded from the sample (N = 1,321 
observations).  
In the case of subjects having multiple contraceptive methods listed at one 
encounter (e.g., pills and an IUD), preference was defaulted to the most effective method 
to produce only one primary method for each clinic encounter. For subjects having 
multiple clinic encounters during the same period, while receiving the same contraceptive 
method (i.e., refilling pill/patch/ring/DMPA prescription), the method was only counted 
once per period (N = 9,457 observations). The unit of analysis for method uptake is a new 
contraceptive visit (prescriptions refills, IUD reinsertions after expulsions, and follow up 
DMPA injection visits were excluded). Data cleaning was done as a first step to detect 
missing or invalid variables. PPAU has a number of “dummy” or “test patients” in the 
medical record system that do not reflect any individual patient; the list of these medical 
records numbers were obtained from administrative staff prior to analysis and these 
observations were excluded from the sample. 
 
2.6 Variable Specification 
Definitions for the variables and coding used in the empirical work appear in 



















































Table 1. Variable Definitions and Coding 
 
Variable Description Coding 
Period Clinic encounter occurring in 




Poverty Status Calculations based on family 
size and family income in 
relation to Federal Poverty 
Status % 
< 100% FPL (0); > 
100% FPL(1) 
  
Age  Age of subject at time of clinic 
encounter 
< 18(0); 18–24(1); 25–
34(2); 35+(3) 
Ever Been Pregnant Subject ever reported a prior 
pregnancy  
No(0) or Yes(1) 
Salt Lake County Resident County of residence  Yes(0) or No(1) 
Race/Ethnicity Ethnicity of subject White non-Hispanic(1); 
Hispanic(2) or Other(3) 
Clinic Location Clinic location that the clinic 
encounter occurred at  
West Valley, Salt Lake 
or South Jordan 
Contraceptive Method Contraceptive method types Cu IUD: (Copper IUD) 
DMPA: (Depo Shot) 
ENG Implant: 
(Implant) 





Contraceptive methods grouped 
into two categories: HER-C (Cu 
IUD, ENG Implant, LNG IUD ) 
and non-HER-C (Pill, Patch, 











3.1 Statistical Analyses 
First, demographic characteristics are compared by which period the clinic visit 
fell within (control or intervention).Then, demographics are compared by whether or not 
subjects selected a HER-C or non-HER-C method of contraception. Comparisons were 
made on the bivariate level using chi-square and standard y-tests. Demographic 
differences could occur between the two study periods, as this study lacked random 
assignment. The regression analysis will include all covariates to control for potential 
differences in demographics.   
Logistic regression models are used to find an association between selecting a 
HER-C method during either the control or the intervention period while controlling for 
covariates. Unadjusted logistic regression analysis was performed on each of the 
covariates (age, living in Salt Lake County, race/ethnicity, pregnancy history, clinic 
location, and study period) and the dependent variable (selecting a HER-C method) prior 
to estimating the final multivariate model. Poverty status was excluded from the analyses 
due to 99% of the sample falling <100% Federal Poverty Line (FPL). Robust standard 
errors were using to account for the fact that individual patients may have multiple clinic 
visits. These models show no evidence of multicollinearity as all variance inflation factor 
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values fall within normal range.  
Multinomial logistic regression was performed to further analyze the different 
types of contraceptives available using robust standard errors to adjust for multiple 
observations from the same patient. HER-C methods were isolated for the analysis; the 
copper IUD, the hormonal IUD the implant. The comparison group for the model was 
women choosing the pill/patch/ring or the DMPA shot. All data analysis was performed 










4.1 Descriptive Results 
Demographics for the sample were compared across the control and the 
intervention periods (Table 2). No statistically significant differences were observed for 
race/ethnicity, poverty status, or county of residence. White, non-Hispanic women 
compromise the majority of participants (56%), with 99% of subjects being below 100% 
Federal Poverty Level (FPL) and 79% of the sample residing in Salt Lake County. There 
were no significant differences by location between the two periods; West Valley 
remained the highest volume clinic accounting for 49% of all clinic encounters during the 
two periods. Overall, 52% of the sample was between the ages of 18–24 and 40% 
reported having at least one prior pregnancy. After the intervention, a statistically 
significant change in the age composition is observed with a decrease in the percent of 
subjects under the age of 18 (7% to 4%) and an increase in the percent of subjects 
between the ages of 18–24 (50% to 54%).  
Demographic differences are noted between the control and the intervention 
cohort, the most significant being age. We could not randomize and create comparable 
cohorts in this study design. Multivariate models were used to control for numerous 
potiential confounding variables.  
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For overall method selection during the control period, 16% of the sample chose a 
HER-C method compared to 26% in the intervention period (p = < 0.001; Table 3).  The 
implant had the largest proportional increase from 4% in the control period to 11% after 
the intervention when the cost barrier was removed.Although the pill/patch/ring remained 
popular choices in both periods, there was a decrease from 55% in the control period to 
48% after the invention (p = < 0.001).  Use of the DMPA shot decreased in usage after 
the cost barrier was removed, 30% to 26% (p = < 0.001).   
When comparing covariates based on whether or not a woman chose a HER-C 
method, there was a statistically significant difference for age and pregnancy history 
(Table 4). Of the clinic encounters where a non-HER-C method was selected, 60% were 
24 years of age or younger, whereas 52% selecting a HER-C method were 25 years of 
age or older (p = < 0.001). Clinic location was associated with method selection, as 82% 
of the women seen at the South Jordan clinic chose a non-HER-C method compared to 
only 18% selecting a HER-C method over both periods. Pregnancy history also seemed to 
be associated with selecting a HER-C method, as 53% of women selecting a HER-C 
method reported at least one prior pregnancy (p = < 0.001). 
 
4.2 Analytical Results 
The multiple logistics regression model specification was statistically significant 
(Table 5). The odds of a subject selecting a HER-C method was 1.86 times more likely 
during the intervention period compared to the control period (OR = 1.857 with CI 95% 
[1.632, 2.112]). Subjects between the ages of 25–34 were 1.19 times more likely to select 
a HER-C method and subjects under the age of 18 were less likely to select a HER-C 
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method compared to the referent group (age 18–24). Subjects with at least one reported 
prior pregnancy were 1.55 times more likely to select a HER-C method compared to 
subjects who were nulliparous. South Jordan clinic encounters were less likely to select a 
HER-C method compared to West Valley (p = < 0.05). The strongest predictor of 
selecting a HER-C method was presenting to a clinic during the intervention period 
compared to the control period.  
In the multinomial regression model, the relative risk of selecting an implant was 
3.18 times more likely than selecting a pill/patch/ring during the intervention period 
when all other covariates were held constant (Table 6).  Selecting the hormonal IUD or 
implant was more likely during the intervention period compared to the pill/patch/ring 
while holding all covariates constant. Subjects aged 25–34 were more likely than referent 
group (18–24) to select a copper  IUD compared to the pill/patch/ring (p = < 0.001). 
Selecting the DMPA shot during the intervention period compared to the pill/patch/ring 
was not statistically significant.  Subjects identifying as Hispanic, non-White were more 
likely than White, non-Hispanic women to select an implant compared to pill/patch/rings 
(p = < 0.05). Having a prior pregnancy was also a predictor for women selecting all 
HER-C methods compared to pill/patch/ring.  
A sensitivity analysis was conducted for a subcohort. In this analysis, all clinic 
visit encounters were removed one month before the intervention period, and one month 
after the initiation to account for potential overlap during the transition of the two study 
periods.  The subcohort demographics were similar to the primary cohort. Confidence 
intervals were overlapping and there were no significant differences. The effects of this 
sensitivity analysis are similar in magnitude and effect for the primary analytic cohort, 
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demonstrating that the analysis was robust, suggesting little, if any, contamination across 









Table 2. Individual Patient Demographic Characteristics by Period  
 
(N = 4,481) 
       
  
 
  Control Period Intervention Period  Total 
  N % N % N % 
Age (years)       
<18 181 7% 75 4% 256 5% 
18–24 1,396 50% 1,119 54% 2,515 52% 
25–34 901 32% 643 31% 1,544 32% 
35+ 298 11% 228 11% 526 11% 
        
c2  (3) = 
22.8951 
Pr = 0.000 
  
    
        
Living in Salt 
Lake County  
     
Yes 2,201 79% 1,613 78% 3,814 79% 
        
c2   (1) = 0.9787  
Pr = 0.323 
      
       
Race/Ethnicity       
White, non-
Hispanic 1,554 56% 1,167 57% 2,721 56% 
Hispanic 948 34% 647 31% 1,595 33% 
Other 274 10% 251 12% 525 11% 
        
c2  (2) = 8.6135  
Pr = 0.013   
    




      
No 1,687 61% 1,212 59% 2,899 60% 
Yes 1,089 39% 853 41% 1,942 40% 
       
c2  (2) = 2.1293 
Pr = 0.145 








Table 3. Contraceptive Method Distribution by Period  
 
(N = 6,021) 
 
Clinic Location       
Salt Lake Clinic 1,003 34% 999 32% 2,002 33% 
South Jordan Clinic 507 17% 538 17% 1,045 17% 
West Valley Clinic 1,412 48% 1,562 50% 2,974 49% 
  
     
 Control Period Intervention Period  Total 
 N % N % N % 
       
c2  (2) = 
3.2927 
Pr = 0.193 
      
       
Contraceptive 
Method  
     
Cu IUD 146 5% 173 6% 319 5% 
DMPA 867 30% 810 26% 1,677 28% 
ENG Implant 120 4% 356 11% 476 8% 
LNG IUD 190 7% 269 9% 459 8% 
Pill/Patch/Ring 1,599 55% 1,491 48% 3,090 51% 
        
c2  (5) = 
133.5149 
Pr = 0.000 
  
    
        
HER-C 
Method 
      
No 2,466 84% 2,301 74% 4,767 79% 
Yes 456 16% 798 26% 1,254 21% 
        
c2  (1) = 
93.8617 
Pr = 0.000 
  
    
Total 2,922 49% 3,099 51% 6,021  
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Table 4. Individual Patient Demographic Characteristics by Selecting  
non-HER-C versus HER-C Method 
 
(N = 4,841)      
      
  Non HER-C   HER-C  Total 
  N % N % N % 
Age (years)        
<18 234 6% 22 2% 256 5% 
18–24 2,106 54% 409 45% 2,515 52% 
25–34 1,192 30% 352 38% 1,544 32% 
35+ 394 10% 132 14% 526 11% 
        
c2  (3) = 57.6276 
Pr = 0.000   
    
        
Living in Salt 
Lake County  
     
Yes 3,119 79% 695 76% 3,814 79% 
        
c2  (1) = 
6.8892 
Pr = 0.032 
      
       
Race/Ethnicity       
White, non-
Hispanic 2,242 57% 479 52% 2,721 56% 
Hispanic 1,269 32% 326 36% 1,595 33% 
Other 415 11% 110 12% 525 11% 
        
c2  (2) = 
6.8892 
 Pr = 0.032 
  
    




      
No 2,467 63% 432 47% 2,899 60% 
Yes 1,459 37% 483 53% 1,942 40% 
        
c2  (1) = 
75.4075 
Pr = 0.000 





Table 5. Logistic Regression Model Table  
 
(N = 6,021) 
  
 Model 1  Model 2  
 Unadjusted CI 95% Adjusted CI 95% 
     
Age     
<18 0.452*** [0.301,0.679] 0.550** [0.363,0.831] 
18–24 1 [1,1] 1 [1,1] 
25–34 1.398*** [1.219,1.603] 1.191* [1.021,1.288] 
35+ 1.479*** [1.221,1.804] 1.142 [0.915,1.426] 
     
Race/Ethnicity     
White, non-
Hispanic 
1 [1,1] 1 [1,1] 
Hispanic 1.61* [1.015,1.327] 0.976 [0.844,1.128] 
Other 1.101 [0.895,1.355] 0.998 [0.807,1.235] 
     
Living in Salt 
Lake County 
    
No 1 [1,1] 1 [1,1] 
Yes 0.848* [0.729,0.985] 0.834** [0.715,0.974] 




    
No 1 [1,1] 1 [1,1] 
Yes 1.725*** [1.522,1.956] 1.548*** [1.327,1.806] 
     
Period     
Control 1 [1,1] 1 [1,1] 
Intervention 1.875*** [1.650,2.132] 1.857*** [1.632,2.112] 
     
Clinic Location     
West Valley 1 [1,1] 1 [1,1] 
Salt Lake 0.904 [0.787,1.038] 1.053 [0.906,1.224] 
South Jordan 0.709*** [0.519,0.852] 0.788* [0.651,0.953] 
 
 
Notes:  * p  < 0.05  
** p  < 0.01 







Table 6. Multinomial Logistic Regression Table  
 
(N = 6,021) 
 
a. DMPA Shot 
 
 Model 1  Model 2  
 Unadjusted CI 95% Adjusted CI 95% 
Age     
<18 0.938 [0.718,1.225] 0.995 [0.758,1.307] 
18–24 1 [1,1] 1 [1,1] 
25–34 0.760*** [0.663,0.872] 0.658*** [0.568,0.764] 
35+ 1.243* [1.019,1.515] 0.944 [0.757,1.178] 
     
Race/Ethnicity     
White, non-
Hispanic 
1 [1,1] 1 [1,1] 
Hispanic 1.668*** [1.467,1.897] 1.529*** [1.328,1.761] 
Other 1.333** [1.093,1.627] 1.334** [1.092,1.630] 
     
Ever Been 
Pregnant 
    
No 1 [1,1] 1 [1,1] 
Yes 1.270*** [1.125,1.435] 1.225*** [1.055,1.422] 
     
Living in Salt 
Lake County 
    
Yes 1.187* [1.020,1.382] 1.118 [0.958,1.305] 
     
Period     
Control 1 [1,1] 1 [1,1] 
Intervention 1.002 [0.890,1.129] 0.983 [0.871,1.109] 
     
Clinic Location     
West Valley 1 [1,1] 1 [1,1] 
Salt Lake  0.754*** [0.652,0.872] 0.755*** [0.653,0.873] 
South Jordan 1.013 [0.855,1.200] 1.011 [0.853,1.197] 
 
 
Notes:  * p < 0.05 
 ** p < 0.01 








Table 6 Continued 
b. Copper IUD 
 Model 1  Model 2  
 Unadjusted CI 95% Adjusted CI 95% 
Age     
<18 0.527 [0.228,1.216] 0.637 [0.276,1.473] 
18–24 1 [1,1] 1 [1,1] 
25–34 2.226*** [1.722,2.878] 1.683*** [1.269,2.232] 
35+ 2.580*** [1.801,3.698] 1.655* [1.121,1.2.443] 
     
Race/Ethnicity     
White, non-
Hispanic 
1 [1,1] 1 [1,1] 
Hispanic 1.612*** [1.259,2.064] 1.230 [0.952,1.590] 
Other 1.339 [0.914,1.961] 1.219 [0.831,1.786] 
     
Ever Been 
Pregnant 
    
No 1 [1,1] 1 [1,1] 
Yes 2.631*** [2.079,3.329] 1.937*** [1.475,2.545] 
     
Living in Salt 
Lake County 
    
Yes 0.894 [0.678,1.179] 0.874 [0.659,1.160] 
     
Period     
Control 1 [1,1] 1 [1,1] 
Intervention 1.271* [1.008,1.601] 1.257 [0.997,1.586] 
     
Clinic Location     
West Valley 1 [1,1] 1 [1,1] 
Salt Lake 1.122 [0.850,1.480] 1.124 [0.852,1.483] 
South Jordan 0.853 [0.597,1.128] 0.842 [0.590,1.202] 
 
 
Notes:  * p < 0.05 
 ** p < 0.01 
 ***p < 0.001 
 




Table 6 Continued 
c. Hormonal IUD 
 Model 1  Model 2  
 Unadjusted CI 95% Adjusted CI 95% 
   
Age     
<18 0.557 [0.305,1.018] 0.618 [0.337,1.131] 
18–24 1 [1,1] 1 [1,1] 
25–34 1.254* [1.007,1.561] 1.125 [0.881,1.438] 
35+ 2.089*** [1.558,2.800] 1.740** [1.250,2.423] 
     
Race/Ethnicity     
White, non-
Hispanic 
1 [1,1] 1 [1,1] 
Hispanic 1.022 [0.824,1.268] 0.877 [0.692,1.112] 
Other 0.770 [0.535,1.107] 0.736 [0.508,1.065] 
     
Ever Been 
Pregnant 
    
No 1 [1,1] 1 [1,1] 
Yes 1.630*** [1.338,1.986] 1.392** [1.088,1.781] 
     
Living in Salt 
Lake County 
    
Yes 0.798 [0.635,1.004] 0.796 [0.631,1.004] 
     
Period     
Control 1 [1,1] 1 [1,1] 
Intervention 1.518*** [1.245,1.852] 1.509*** [1.235,1.843] 
     
Clinic 
Location 
    
West Valley 1 [1.1] 1 [1,1] 
Salt Lake 0.992 [0.785,1.254] 0.994 [0.786,1.255] 
South Jordan 1.063 [0.804,1.405] 1.056 [0.799,1.396] 
 
 
Notes:  * p < 0.05 
 ** p < 0.01 
 ***p < 0.001 




Table 6 Continued  
d. Implant 
 Model 1  Model 2  
 Unadjusted CI 95% Adjusted CI 95% 
Age     
<18 0.319** [0.161,0.632] 0.451* [0.226,0.901] 
18–24 1 [1,1] 1 [1,1] 
25–34 0.906 [0.733,1.120] 0.690** [0.541,0.880] 
35+ 0.852 [0.597,1.215] 0.528** [0.359,0.777] 
     
Race/Ethnicity     
White, non-
Hispanic 
1 [1,1] 1 [1,1] 
Hispanic 1.720*** [1.396,2.120] 1.397** [1.120,1.743] 
Other 1.685*** [1.244,2.280] 1.461* [1.071,1.994] 
     
Ever Been 
Pregnant 
    
No 1 [1,1] 1 [1,1] 
Yes 1.727*** [1.422,2.097] 1.766*** [1.387,2.249] 
     
Living in Salt 
Lake County 
    
Yes 1.019 [0.802.1.294] 0.944 [0.737,1.208] 
     
Period     
Control 1 [1,1] 1 [1,1] 
Intervention 3.182*** [2.557,3.959] 3.077*** [2.470,3.832] 
     
Clinic Location     
West Valley 1 [1,1] 1 [1,1] 
Salt Lake 0.837 [0.665,1.053] 0.837 [0.665,1.053] 
South Jordan 0.519*** [0.373,0.724] 0.518*** [0.372,0.723] 
 
 
Notes:  * p < 0.05 
 ** p < 0.01 









With no-cost access to all methods of contraception, women increased uptake of 
HER-C by 50%. The largest increase occurred with implant use, which increased from 
4% of women in the control period to 11% with free care. These data contribute to policy 
implications about women in Salt Lake County and method choice selection when 
contraception is free. With the uncertain political climate and future of Title X funding, 
this data can be supportive of the importance to keep contraceptive options available and 
accessible. This local demonstrated desire for HER-C methods will allow for 
policymakers to make informed decisions on behalf of their constituents.   
In the multinomial regression model, selecting the copper IUD was not 
significantly different from selecting DMPA or the contraceptive pill, patch, or ring. But 
the odds ratio of selecting the hormonal IUD and the implant relative to the non-HER-C 
methods were significantly different after the cost barrier was removed. The insignificant 
difference with the copper IUD and the non-HER-C methods may have occurred because 
prior to the free intervention, patients were able to obtain this method on a sliding-fee-
scale, whereas that was not available for the hormonal IUD and implant.  
Previous research states that in the United States the greatest proportion of HER-
C users are between the ages 25–35 and parous (Branum & Jones, 2015). The findings of 
		
32 
this current analysis were similar, in that 51% of women selecting a HER-C method were 
25 years of age or older. Of the women who chose a HER-C method, 53% had reported at 
least one prior pregnancy compared to 63% selecting a non-HER-C method who were 
nulliparous.  
Although the proportion of women selecting HER-C methods in this study may 
not be as high as other similar projects (CHOICE HER-C selection = 76%), it is worth 
mentioning a recent survey that asked clinicians what percentage of contracepting women 
would use a HER-C method if barriers (including cost) were removed. This group of 100 
experts estimated that 25–29% of women would select a HER-C method if barriers were 
removed (Foster et al., 2015). This study’s current findings more closely approximate this 
estimate as the proportion of women initiating HER-C usage increased from 16% during 
the baseline control period to 26% after the no-cost intervention.  
The usage increase of HER-C methods was overall significant, yet still a large 
portion of the sample selected non-HER-C methods after the intervention. In addressing 
why the removal of cost barriers did not lead to larger gains in HER-C usage, it is 
important to think of social and cultural contexts for individuals. There are other factors 
that can affect a woman’s contraceptive decisions besides cost.  Public opinion on 
contraceptive methods may affect method selection. Women may select a more 
commonly known method, as HER-C methods are relatively new and potentially 
unknown. Social relations can be a part of contraceptive decision making, as family or 
friends’ perceptions and own experiences can create positive or negative assoaciations 
with different contraceptive methods. 
This study assessed the impact of a cost reduction intervention on the uptake of 
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HER-C methods. Going forward, life course theory could be used to reveal the multiple 
forces that shape contraceptive decision making. This perspective highlights that the 
individuals’s own characteristics and life experiences influence choice, within limitations 
of what is available to them. HER-C method selection can vary depending on an 
individual’s past experiences, life timing or age and relationship status.  Economic factors 
and method effectiveness are important factors for contraceptive method selection, but 
further investigation of other life course factors should be considered if we are to gain a 
more complete understanding of the circumstances that influence women’s contraception 
choices.   
 
5.1 Strengths 
The innovative features of this project were that the clinics observed are 
established family planning clinics that prior to the interventions, already implemented 
standardized, client-centered contraceptive counseling and same-day device insertion. 
With the contraceptive counseling in place, this project tackles another barrier to 
contraceptive access: cost. While similar projects used concentrated recruitment tactics, 
this project was observational in nature and includes both a control group from the same 
population served at the same clinics and an intervention group where the only change in 
clinical service was removal of the cost barrier. The relatively large sample and 
prospective nature are notable strengths. The observational nature of this study translates 
into practical practice of protocols for Planned Parenthood Federation of America, and 
makes these findings generalizable to national clinics. The qualification algorithm created 
is highly reproducible and can be used for future electronic medical record data research 
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to look at contraceptive method mix uptake.  This study looked at both odds ratios and 
relative risk calculations, which supports strong implications for causation.  
 
5.2 Limitations 
This project had some noteworthy limitations. First, the demographics available 
for the sample were derived from PPAU’s clinical patient management system that lacks 
certain demographics that would be helpful to control for including education level and 
religious affiliation. A second limitation falls within the qualifying criteria for this study. 
This project limited participation to women initiating a new contraceptive method, 
whereas women continuing their same method of contraception were excluded from this 
sample. Distribution of method selection may look different if these “continued use” 
women were included in the sample. Another limitation within the qualifying criteria is 
the inclusion of only self-pay patients in the sample. Though the majority of PPAU’s 
patients are uninsured (86% for 2015), the proportions may have varied if women with 
insurance were included in this sample. As the intervention was not randomized, it limits 
our ability to determine a definitive conclusion about causality. Another uncontrollable 
influence could have been patients using word-of-mouth to spread knowledge of the 
study and the ability to acquire free contraception to friends.   
Some external factors could not be controlled for in the analysis. For example, 
2016 was an election year with Planned Parenthood and women’s health often in the 
media. Locally, in August of 2015, Utah’s Governor Gary Herbert gave a verbal directive 
to the state to cut funding to PPAU. It is not possible to estimate how this historical event 
may have impacted women’s contraceptive choice. During the study period it is also 
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possible that favorable and unfavorable media coverage of IUDs and implants could have 
also affected HER-C use. Included in this could have been introduction and coverage of 
the Liletta IUD. PPAU clinics incorporated use of Liletta into care at the participating 
clinics prior to onset of the study. We are not in a position to control for these potential 
influences.  
While we did not include cost-savings analysis in this study, these findings 
suggest meaningful potential savings for Medicaid. Overall public funding for births has 
increased with recent Medicaid eligibility expansions. With 99% of the sample earning 
less than 100% of the FPL, these results demonstrate a need for widely available 
contraceptive services, particularly for lower income women as a potential cost savings 
benefit to the State.  
 
5.3 Future Direction  
This project provides insights regarding future best practices for family planning. 
Research and literature has shown that there are other barriers to accessing contraception 
besides cost. In a recent analysis of peer-reviewed papers published on HER-C methods, 
the most common barrier identified was cost, followed by women’s knowledge of safety, 
method acceptability and use, and provider training (Foster et al., 2015). Future directions 
for research should bring attention to removing other barriers in order to continue to 
reduce rates of unintended pregnancy.  
By effectively demonstrating a desire for HER-C methods in this project, 
continued efforts are needed to promote access to and increase awareness for HER-C 
methods.  While there was an uptake in all HER-C methods, demand for the implant 
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exceeded that for both the hormonal and copper IUD. This could have important 
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   YEARLY 0 - 11,880 11,881 - 17,820 17,821 - 23,760 23,761 - 29,700 29,701 OR MORE
1    MONTHLY 0 - 990 991 - 1,485 1,486 - 1,980 1,981 - 2,475 2,476 OR MORE
   WEEKLY 0 - 228 229 - 343 344 - 457 458 - 571 572 OR MORE
   YEARLY 0 - 16,020 16,021 - 24,030 24,031 - 32,040 32,041 - 40,050 40,051 OR MORE
2    MONTHLY 0 - 1,335 1,336 - 2,003 2,004 - 2,670 2,671 - 3,338 3,339 OR MORE
   WEEKLY 0 - 308 309 - 462 463 - 616 617 - 770 771 OR MORE
   YEARLY 0 - 20,160 20,161 - 30,240 30,241 - 40,320 40,321 - 50,400 50,401 OR MORE
 3    MONTHLY 0 - 1,680 1,681 - 2,520 2,521 - 3,360 3,361 - 4,200 4,201 OR MORE
   WEEKLY 0 - 388 389 - 582 583 - 775 776 - 969 970 OR MORE
   YEARLY 0 - 24,300 24,301 - 36,450 36,451 - 48,600 48,601 - 60,750 60,751 OR MORE
4    MONTHLY 0 - 2,025 2,026 - 3,038 3,039 - 4,050 4,051 - 5,063 5,064 OR MORE
   WEEKLY 0 - 467 468 - 701 702 - 935 936 - 1,168 1,169 OR MORE
   YEARLY 0 - 28,440 28,441 - 42,660 42,661 - 56,880 56,881 - 71,100 71,101 OR MORE
5    MONTHLY 0 - 2,370 2,371 - 3,555 3,556 - 4,740 4,741 - 5,925 5,926 OR MORE
    WEEKLY 0 - 547 548 - 820 821 - 1,094 1,095 - 1,367 1,368 OR MORE
   YEARLY 0 - 32,580 32,581 - 48,870 48,871 - 65,160 65,161 - 81,450 81,451 OR MORE
6    MONTHLY 0 - 2,715 2,716 - 4,073 4,074 - 5,430 5,431 - 6,788 6,789 OR MORE
   WEEKLY 0 - 627 628 - 940 941 - 1,253 1,254 - 1,566 1,567 OR MORE
   YEARLY 0 - 36,730 36,731 - 49,905 49,906 - 73,460 73,461 - 91,825 91,826 OR MORE
7    MONTHLY 0 - 3,061 3,062 - 4,159 4,160 - 6,122 6,123 - 7,652 7,653 OR MORE
   WEEKLY 0 - 706 707 - 960 961 - 1,413 1,414 - 1,766 1,767 OR MORE
8    YEARLY 0 - 40,890 40,891 - 61,335 61,336 - 81,780 81,781 - 102,225 102,226 OR MORE
9    YEARLY 0 - 45,050 45,051 - 67,575 67,576 - 90,100 90,101 - 112,625 112,626 OR MORE
10    YEARLY 0 - 49,210 49,211 - 73,815 73,816 - 98,420 98,421 - 123,025 123,026 OR MORE
11    YEARLY 0 - 53,370 53,371 - 80,055 80,056 - 106,740 106,741 - 133,425 133,426 OR MORE
12    YEARLY 0 - 57,530 57,531 - 86,295 86,296 - 115,060 115,061 - 143,825 143,826 OR MORE
13    YEARLY 0 - 61,690 61,691 - 92,535 92,536 - 123,380 123,381 - 154,225 154,226 OR MORE
14    YEARLY 0 - 65,850 65,851 - 98,775 98,776 - 131,700 131,701 - 164,625 164,626 OR MORE
15    YEARLY 0 - 70,010 70,011 - 105,015 105,016 - 140,020 140,021 - 175,025 175,026 OR MORE
FOR	FAMILY	UNITS	WITH	MORE	THAN	15	MEMBERS	ADD	$4,160	FOR	EACH	ADDITIONAL	FAMILY	MEMBER.
SOURCE: FEDERAL REGISTER, Jan. 25, 2016
ABCDE
PLANNED PARENTHOOD ASSOCIATION OF UTAH
FEDERAL POVERTY INCOME GUIDELINES
Jan-16
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OF CONTRACEPTIVE METHODS FOR INSURED, 
 



















































	 	 	 	
Paragard	IUD	 950	 460	 0	
Mirena	IUD	 1010	 560	 Does	not	
slide	
Liletta	IUD	 1010	 460	 0	
	 	 	 	
Implant	 915	 610	 Does	not	
slide	
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Planned Parenthood’s Contraceptive Conversations Script 
Staff Name:   ___________________________ Clinic: ____________________ 
Date: ___________________ 
Checklist 
  Hi my name is _____ and I am a Clinical Assistant.  We are experts & we are here 
for you.   
  We want to help you make the best decision for you. 
  GIVE CARD: Call us anytime and I or one of my teammates will be happy to 
help.  Here’s a card with our phone number & my name on it.  Give card with your 
first name written on it. 
  CHART: Group A methods are the best at preventing pregnancy and easiest to use  
- our provider puts in place for you & then you don’t do anything until or if you 
want to be pregnant.  Group B are also very good at preventing pregnancy when 
used correctly and you have to do something daily, weekly, or monthly to make 
them work.   Group C are things you have to do every time you have sex and are 
not as good at preventing pregnancy. 
-What questions do you have about the methods chart? Wait 7 seconds   




















1. What do you like about this method? What do you dislike? 
2. How would people important to you, like your partner, family or friends feel about you using this 
method? 
3. How does this method fit with who you are-your lifestyle?  How does this method fit with how you see 
yourself? 
4. If you decided to use this method, how easy or hard would be to use it correctly? 
5. What feelings do you have about this method? 
 
  INFO SHEETS: Show patient info sheet & point “These are the side effects.  Most 
side effects are temporary, usually lasting 2-3 months. Which of these side effects 
might be hard for you personally to deal with? What would you do to deal with 
that?” Patient makes the plan 
  ACCURATE USE: Group B or C only 
-What is your plan to be sure you take your pill every day? (or put in your ring on 
time or come back in for your next shot or change your patch).  
-What would your back-up plan be, like if you miss a pill/ring/shot?  Discuss EC. 
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PPAU EPM/EHR Clinic encounter descriptions that automatically qualify: 
 
New Contraceptive Visit 
 
New Teen Contraceptive Visit 
 





The following clinic encounter descriptions are reviewed for and included 
in the sample if the patient received a new method of contraception:  
 
Office Visit, New or New Office Visit 
 
Preventive visit, New 
 
IUD or CI removal 
 




Pregnancy test walk-in 
 
Established Contraceptive Visit 
 
Established Teen Contraceptive Visit 
 



































Table 7. Demographics by Period of Subcohort  
 
(N = 3,392) 
(N = 3,392) 
Total   2,047  60%  1,345  40% 3,392  
 
  
  Control Period Intervention Period  Total 
  N % N % N % 
Age (years)       
<18 133 6% 53 4% 186 5% 
18-24 1,045 51% 723 54% 1,768 52% 
25-34 649 32% 417 31% 1,066 31% 
35+ 220 11% 152 11% 372 11% 
        
χ2  (3) = 11.1693 
Pr = 0.011   
    
        
Living in Salt 
Lake County  
     
Yes 1,163 61% 1,032 77% 2,645 78% 
        
χ2   (1) = 2.0246  
Pr = 0.155 
      
       
Race/Ethnicity       
White, non-
Hispanic 1,160 57% 769 57% 1,929 57% 
Hispanic 691 34% 409 30% 1,100 32% 
Other 196 10% 167 12% 363 11% 
        
χ2  (2) = 8.9652  
Pr = 0.011   
    
        
Ever Been 
Pregnant Before 
      
No 1,241 61% 801 60% 2,042 60% 
Yes 806 39% 544 40% 1,350 40% 
       
χ2  (2) = 0.3889 
Pr = 0.533 
      





Table 8. Demographics non-HER-C versus HER-C Methods of Subcohort 
 
(N = 3,392) 
	
  Non HER-C   HER-C  Total 
  N % N % N % 
Age (years)        
<18 173 6% 13 2% 186 5% 
18-24 1,505 54% 263 45% 1,768 52% 
25-34 836 30% 230 39% 1,066 31% 
35+ 288 10% 84 14% 372 11% 
        
χ2  (3) = 41.7585 
Pr = 0.000   
    
        
Living in Salt 
Lake County  
     
Yes 2,203 79% 442 75% 2,645 78% 
        
χ2  (1) = 3.9004 
Pr = 0.048 
      
       
Race/Ethnicity       
White, Non-
Hispanic 1,631 58% 298 51% 1,929 57% 
Hispanic 879 31% 221 37% 1,100 32% 
Other 292 10% 71 12% 363 11% 
        
χ2  (2) = 11.8345 
 Pr = 0.003   
    
       
Ever Been 
Pregnant Before 
      
No 1,779 63% 263 45% 2,042 60% 
Yes 1,023 37% 327 55% 1,350 40% 
        
χ2  (1) = 72.7709 
Pr = 0.000 
 





Table 9. Logistic Regression of Subcohort 
 
(N = 4,992) 
 
 Model 1  Model 2  
 Unadjusted CI 95% Adjusted CI 95% 
     
Age     
<18 0.450*** [0.287,0.705] 0.559* [0.353,0.884] 
18-24 1 [1,1] 1 [1,1] 
25-34 1.424*** [1.225,1.654] 1.166 [0.984,1.381] 
35+ 1.484*** [1.196,1.834] 1.073 [0.834,1.356] 
     
Race/Ethnicity     
White, Non-
Hispanic 
1 [1,1] 1 [1,1] 
Hispanic 1.270* [1.097,1.470] 1.052 [0.898,1.231] 
Other 1.187 [0.948,1.486] 1.061 [0.842,1.336] 
     
Living in Salt 
Lake County 
    
No 1 [1,1] 1 [1,1] 
Yes 0.866 [0.734,1.023] 0.851 [0.718,1.010] 




    
No 1 [1,1] 1 [1,1] 
Yes 1.851*** [1.614,2.124] 1.653*** [1.395,1.958] 
     
Period     
Control 1 [1,1] 1 [1,1] 
Intervention 1.815*** [1.578,2.087] 1.789*** [1.554,2.059] 
     
Clinic 
Location 
    
West Valley 1 [1,1] 1 [1,1] 
Salt Lake 0.863 [0.742,1.005] 1.035 [0.906,1.224] 






Table 10. Multinomial Regression of Subcohort 
 
(N = 4,992) 
 
a. DMPA Shot 
 Model 1  Model 2  
 Unadjusted CI 95% Adjusted CI 95% 
Age     
<18 0.970 [0.722,1.302] 1.022 [0.757,1.379] 
18-24 1 [1,1] 1 [1,1] 
25-34 0.731*** [0.628,0.851] 0.628*** [0.532,0.740] 
35+ 1.251* [1.008,1.554] 0.947 [0.743,1.206] 
     
Race/Ethnicity     
White, Non-Hispanic 1 [1,1] 1 [1,1] 
Hispanic 1.641*** [1.424,1.891] 1.495*** [1.280,1.745] 
Other 1.378** [1.108,1.713] 1.371** [1.101,1.706] 
     
Ever Been Pregnant     
No 1 [1,1] 1 [1,1] 
Yes 1.272*** [1.112,1.454] 1.260** [1.068,1.488] 
     
Living in Salt Lake 
County 
    
Yes 1.236* [1.044,1.462] 1.174 [0.989,1.393] 
     
Period     
Control 1 [1,1] 1 [1,1] 
Intervention 0.981 [0.861,1.119] 0.965 [0.845,1.103] 
     
Clinic Location     
West Valley 1 [1,1] 1 [1,1] 
Salt Lake  0.769*** [0.656,0.902] 0.770** [0.656,0.903] 
South Jordan 1.003 [0.832,1.208] 1.000 [0.830,1.204] 
 
 
Notes:   
*p < 0.05 
 ** p < 0.01 
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Table 10 Continued 
 
b. Copper IUD 
 Model 1  Model 2  
 Unadjusted CI 95% Adjusted CI 95% 
Age     
<18 0.654 [0.281,1.522] 0.797 [0.342,1.856] 
18-24 1 [1,1] 1 [1,1] 
25-34 2.400*** [1.817,3.170] 1.770*** [1.309,2.392] 
35+ 2.767*** [1.883,4.608] 1.717* [1.137,1.2.592] 
     
Race/Ethnicity     
White, Non-Hispanic 1 [1,1] 1 [1,1] 
Hispanic 1.685*** [1.293,2.197] 1.289 [0.981,1.694] 
Other 1.410 [0.938,2.120] 1.286 [0.854,1.937] 
     
Ever Been Pregnant     
No 1 [1,1] 1 [1,1] 
Yes 2.806*** [2.177,3.618] 2.047*** [1.538,2.726] 
     
Living in Salt Lake 
County 
    
Yes 0.955 [0.706,1.290] 0.937 [0.688,1277] 
     
Period     
Control 1 [1,1] 1 [1,1] 
Intervention 1.205 [0.940,1.543] 1.189 [0.927,1.525] 
     
Clinic Location     
West Valley 1 [1,1] 1 [1,1] 
Salt Lake 1.176 [0.875,1.580] 1.179 [0.877,1.583] 




Notes:   
* p < 0.05 
 ** p < 0.01 













Table 10 Continued 
 
c. Hormonal IUD 
 Model 1  Model 2  
 Unadjusted CI 95% Adjusted CI 95% 
   
Age     
<18 0.451* [0.217,0.936] 0.506 [0.244,1.049] 
18-24 1 [1,1] 1 [1,1] 
25-34 1.149 [0.900,1.467] 0.980 [0.745,1.291] 
35+ 2.048*** [1.488,2.818] 1.568* [1.093,2.251] 
     
Race/Ethnicity     
White, Non-Hispanic 1 [1,1] 1 [1,1] 
Hispanic 1.119 [0.883,1.417] 0.939 [0.729,1.214] 
Other 0.854 [0.576,1.266] 0.807 [0.539,1.208] 
     
Ever Been Pregnant     
No 1 [1,1] 1 [1,1] 
Yes 1.725*** [1.387,2.145] 1.485** [1.128,1.955] 
     
Living in Salt Lake 
County 
    
Yes 0.785 [0.610,1.011] 0.783 [0.607,1.011] 
     
Period     
Control 1 [1,1] 1 [1,1] 
Intervention 1.479*** [1.188,1.842] 1.452*** [1.165,1.809] 
     
Clinic Location     
West Valley 1 [1.1] 1 [1,1] 
Salt Lake 0.887 [0.684,1.150] 0.889 [0.686,1.152] 
South Jordan 1.001 [0.735,1.362] 0.992 [0.729,1.349] 
     
     
 
Notes:   
* p < 0.05 
 ** p < 0.01 
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d. Implant 
 Model 1  Model 2  
 Unadjusted CI 95% Adjusted CI 95% 
Age     
<18 0.355** [0.172,0.735] 0.521 [0.249,1.092] 
18-24 1 [1,1] 1 [1,1] 
25-34 0.934 [0.740,1.178] 0.681** [0.519,0.893] 
35+ 0.819 [0.552,1.217] 0.472*** [0.308,0.724] 
     
Race/Ethnicity     
White, Non-Hispanic 1 [1,1] 1 [1,1] 
Hispanic 1.895*** [1.507,2.383] 1.505*** [1.181,1.918] 
Other 1.849*** [1.328,2.574] 1.561** [1.114,2.188] 
     
Ever Been Pregnant     
No 1 [1,1] 1 [1,1] 
Yes 1.866*** [1.508,2.308] 1.942*** [1.481,2.546] 
     
Living in Salt Lake 
County 
    
Yes 1.088 [0.834.1.421] 1.014 [0.769,1.336] 
     
Period     
Control 1 [1,1] 1 [1,1] 
Intervention 3.058*** [2.413,3.875] 2.965*** [2.36,3.763] 
     
Clinic Location     
West Valley 1 [1,1] 1 [1,1] 
Salt Lake 0.863 [0.742,1.005] 0.867 [0.674,1.115] 
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